Form 4 for ABEO ABEONA THERAPEUTICS INC.
Accepted 2025-02-03 00:00:00 ET · period of report 2025-01-31 · accession 0001493152-25-004749 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-03 | 2025-01-31 | ABEO | Alvino Mark | Dir | A - Grant | $0.00 | +36.1K | 100.4K | +56% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-31 | A | A | 36,101 | $0.00 | 100,435 | D | — | — | (F2) All of the restricted stock will vest on January 31, 2026. |